Ergoteles LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 159 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q4 2022$74,082
-91.1%
114,131
-76.5%
0.00%
-89.7%
Q3 2022$835,000
-28.1%
485,434
-48.2%
0.03%
-17.1%
Q2 2022$1,162,000
+198.7%
936,900
+337.8%
0.04%
+150.0%
Q3 2021$389,000
+221.5%
214,000
+367.2%
0.01%
+366.7%
Q2 2021$121,000
+181.4%
45,800
+166.3%
0.00%
-50.0%
Q3 2020$43,00017,2000.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,642,959$25,186,0003.76%
MSD Partners, L.P. 15,151,516$26,061,0002.11%
MSD Partners, L.P. 7,575,758$13,030,0001.05%
MAGNOLIA CAPITAL ADVISORS LLC 418,569$720,0000.61%
STEEL GROVE CAPITAL ADVISORS, LLC 1,080,000$1,858,0000.33%
EAM Investors, LLC 454,625$782,0000.17%
Allred Capital Management, LLC 158,000$271,0000.17%
Boxer Capital, LLC 1,500,000$2,580,0000.14%
GSA CAPITAL PARTNERS LLP 608,037$1,046,0000.14%
CHIRON CAPITAL MANAGEMENT, LLC 116,860$201,0000.14%
View complete list of ZIOPHARM ONCOLOGY INC shareholders